Traditional Chinese medicine composition for treating non-alcoholic fatty liver and preparation method and application thereof

By combining raw Astragalus membranaceus, processed Atractylodes lancea, raw Crataegus pinnatifida, cinnamon, tangerine peel, Gynostemma pentaphyllum, apricot kernel, and chicken gizzard lining, a traditional Chinese medicine preparation suitable for non-alcoholic fatty liver disease of the liver stagnation and spleen deficiency type was prepared, which solved the shortcomings of existing treatment methods and achieved safe and effective treatment results.

CN122398906APending Publication Date: 2026-07-17HUBEI SHIZHEN LABORATORY +1
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
HUBEI SHIZHEN LABORATORY
Filing Date
2026-05-19
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

There is a lack of effective drugs for treating non-alcoholic fatty liver disease in the current technology. Existing treatments, such as lipid-lowering drugs, may lead to abnormal liver function with long-term use. Diet therapy and exercise therapy are not very effective and are difficult to adhere to in the long term.

Method used

A traditional Chinese medicine composition is provided, consisting of raw Astragalus membranaceus, processed Atractylodes lancea, raw Crataegus pinnatifida, cinnamon, tangerine peel, Gynostemma pentaphyllum, apricot kernel, and chicken gizzard lining. It is prepared into decoction, granules, oral liquid, or syrup through steps such as soaking, decocting, filtering, and concentration. It has the effects of strengthening the spleen and removing dampness, promoting qi circulation and removing blood stasis, and is suitable for patients with non-alcoholic fatty liver disease of the liver stagnation and spleen deficiency type.

Benefits of technology

The traditional Chinese medicine composition significantly improves liver function, lowers blood lipid levels, and reduces liver fat accumulation by regulating phlegm-dampness constitution. It has a safe and effective therapeutic effect and is suitable for non-alcoholic fatty liver disease.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122398906A_ABST
    Figure CN122398906A_ABST
Patent Text Reader

Abstract

The present application relates to the field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition for treating non-alcoholic fatty liver and a preparation method thereof. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 3-9 parts of raw astragalus, 1-6 parts of prepared atractylodes rhizome, 2-8 parts of raw hawthorn, 1-4 parts of cassia, 1-6 parts of dried tangerine or orange peel, 2-8 parts of gynostemma pentaphyllum, 1-4 parts of apricot kernel, and 1-4 parts of chicken gizzard. The composition provided by the present application is simple, and raw materials are easy to obtain. Raw astragalus is used as the monarch drug, prepared atractylodes rhizome and gynostemma pentaphyllum are used as the ministerial drug, and cassia, apricot kernel, raw hawthorn, dried tangerine or orange peel and chicken gizzard are used as the auxiliary drug. The monarch, ministerial and auxiliary drugs are reasonably matched, and have the effects of invigorating the spleen, removing dampness, promoting blood circulation and removing phlegm-dampness, which is suitable for the pathogenesis of non-alcoholic fatty liver, and is suitable for non-alcoholic fatty liver patients with liver stagnation and spleen deficiency, and phlegm and blood stasis.
Need to check novelty before this filing date? Find Prior Art